Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Income towards Parent Company: 2010-2023

Historic Income towards Parent Company for SELLAS Life Sciences Group (SLS) over the last 9 years, with Dec 2023 value amounting to -$37.9 million.

  • SELLAS Life Sciences Group's Income towards Parent Company rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 8.31% up from last year.
  • SELLAS Life Sciences Group's Income towards Parent Company amounted to -$37.9 million in FY2023, which was up 8.31% from -$41.3 million recorded in FY2022.
  • SELLAS Life Sciences Group's Income towards Parent Company's 5-year high stood at -$16.8 million during FY2020, with a 5-year trough of -$41.3 million in FY2022.
  • Its 3-year average for Income towards Parent Company is -$33.3 million, with a median of -$37.9 million in 2023.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first increased by 13.14% in 2020, then plummeted by 99.53% in 2022.
  • SELLAS Life Sciences Group's Income towards Parent Company (Yearly) stood at -$19.3 million in 2019, then grew by 13.14% to -$16.8 million in 2020, then decreased by 23.52% to -$20.7 million in 2021, then crashed by 99.53% to -$41.3 million in 2022, then grew by 8.31% to -$37.9 million in 2023.